TOP2A and prostate carcinoma: In addition, TOP2α is used as a proliferation marker in multiple cancer types, including CRC56,57, and elevated levels of TOP2α expression are associated with metastasis in prostate cancer, pancreatic cancer, and breast cancer58–61.